Ewing Sarcoma: Current Management and Future Approaches Through Collaboration, Journal of Clinical Oncology, vol.33, issue.27, 2015. ,
DOI : 10.1200/JCO.2014.59.5256
Children's Oncology Group's 2013 blueprint for research: Bone tumors, Pediatric Blood & Cancer, vol.80, issue.6, pp.1009-1015, 2013. ,
DOI : 10.1002/(SICI)1097-0142(19970715)80:2<317::AID-CNCR21>3.0.CO;2-W
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610028/pdf
Changes in Incidence and Survival of Ewing Sarcoma Patients Over the Past 3 Decades, Journal of Pediatric Hematology/Oncology, vol.30, issue.6, pp.425-430, 2008. ,
DOI : 10.1097/MPH.0b013e31816e22f3
The First European Interdisciplinary Ewing Sarcoma Research Summit, Frontiers in Oncology, vol.2, p.54, 2012. ,
DOI : 10.3389/fonc.2012.00054
The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation, PLoS Genetics, vol.28, issue.7, p.1004475, 2014. ,
DOI : 10.1371/journal.pgen.1004475.s022
The genomic landscape of pediatric Ewing sarcoma. Cancer discovery, pp.1326-1341, 2014. ,
Discovery and saturation analysis of cancer genes across 21 tumour types, Nature, vol.505, issue.7484, pp.495-501, 2014. ,
DOI : 10.1002/ijc.25516
Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer discovery, pp.1342-1353, 2014. ,
Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma Clin Cancer Res, 2015. ,
EWS-FLI1??Utilizes Divergent Chromatin Remodeling Mechanisms to Directly Activate or Repress Enhancer Elements in Ewing Sarcoma, Cancer Cell, vol.26, issue.5, pp.668-681, 2014. ,
DOI : 10.1016/j.ccell.2014.10.004
Epigenome Mapping Reveals Distinct Modes of Gene Regulation and Widespread Enhancer Reprogramming by the Oncogenic Fusion Protein EWS-FLI1 Cell reports, 2015. ,
Reversible LSD1 Inhibition Interferes with Global EWS/ETS Transcriptional Activity and Impedes Ewing Sarcoma Tumor Growth, Clinical Cancer Research, vol.20, issue.17, pp.4584-4597, 2014. ,
DOI : 10.1158/1078-0432.CCR-14-0072
URL : http://clincancerres.aacrjournals.org/content/clincanres/20/17/4584.full.pdf
Predicting genetic interactions from Boolean models of biological networks Integrative biology : quantitative biosciences from nano to macro, pp.921-929, 2015. ,
Somatic chromosomal translocation between Ewsr1 and Fli1 loci leads to dilated cardiomyopathy in a mouse model Scientific reports, p.7826, 2015. ,
Ewing???s sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors, Journal of Clinical Investigation, vol.124, issue.7, pp.3061-3074, 2014. ,
DOI : 10.1172/JCI72399DS1
Polycomb silencers control cell fate, development and cancer, Nature Reviews Cancer, vol.116, issue.11, pp.846-856, 2006. ,
DOI : 10.1016/S0301-472X(00)00620-2
Modeling Initiation of Ewing Sarcoma in Human Neural Crest Cells, PLoS ONE, vol.5, issue.4, p.19305, 2011. ,
DOI : 10.1371/journal.pone.0019305.s004
Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs, Epigenetics, vol.9, issue.12, pp.1613-1625, 2014. ,
DOI : 10.1038/nprot.2008.211
Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer discovery, pp.648-657, 2013. ,
Mesenchymal Stem Cell Features of Ewing Tumors, Cancer Cell, vol.11, issue.5, pp.421-429, 2007. ,
DOI : 10.1016/j.ccr.2007.02.027
LGR5 is Expressed by Ewing Sarcoma and Potentiates Wnt/beta- Catenin Signaling Flow perfusion effects on threedimensional culture and drug sensitivity of Ewing sarcoma, Proceedings of the National Academy of Sciences of the United States of America, pp.10304-10309, 2013. ,
Oncogenes strike a balance between cellular growth and homeostasis. Seminars in cell & developmental biology, 2015. ,
Translational Activation of HIF1?? by YB-1 Promotes Sarcoma Metastasis, Cancer Cell, vol.27, issue.5, pp.682-697, 2015. ,
DOI : 10.1016/j.ccell.2015.04.003
YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1, The Journal of Cell Biology, vol.2011, issue.7, pp.913-929, 2015. ,
DOI : 10.3748/wjg.v13.i30.4126
URL : http://jcb.rupress.org/content/jcb/208/7/913.full.pdf
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma Nature genetics, 2012. ,
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite, Nature Genetics, vol.83, issue.9, pp.1073-1078, 2015. ,
DOI : 10.1093/nar/gks1048
Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis. The Journal of clinical investigation, pp.5275-5290, 2014. ,
Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma, Oncotarget, vol.6, issue.30, pp.30178-93, 2015. ,
DOI : 10.18632/oncotarget.4903
SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma, Clinical Cancer Research, vol.21, issue.18, 2015. ,
DOI : 10.1158/1078-0432.CCR-14-2112
The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin, Oncotarget, vol.6, pp.18875-18890, 2015. ,
PARP-1 inhibition as a targeted strategy to treat Ewing's sarcoma. Cancer research, pp.1608-1613, 2012. ,
Dual Targeting of EWS-FLI1 Activity and the Associated DNA Damage Response with Trabectedin and SN38 Synergistically Inhibits Ewing Sarcoma Cell Growth, Clinical Cancer Research, vol.20, issue.5, pp.1190-1203, 2014. ,
DOI : 10.1158/1078-0432.CCR-13-0901
Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing, Proceedings of the National Academy of Sciences, vol.17, issue.10, pp.1307-1316, 2015. ,
DOI : 10.1200/JCO.2011.41.5703
Assemblages: Functional units formed by cellular phase separation, The Journal of Cell Biology, vol.9, issue.5, pp.579-588, 2014. ,
DOI : 10.1038/msb.2009.80
URL : http://jcb.rupress.org/content/jcb/206/5/579.full.pdf